Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT03813862 · ClinicalTrials.gov registry record

Observational Pharmaco-Epidemiology Research & Analysis

A clinical trial of Cardiovascular Diseases and HIV/AIDS, sponsored by Epividian.

Recruiting
Registry status
2,000,000
Enrollment target
1
Study location

NCT03813862: Recruiting study of Cardiovascular Diseases and HIV/AIDS, sponsored by Epividian.

NCT03813862 is a study of Cardiovascular Diseases and HIV/AIDS that is actively recruiting participants, run by Epividian. The registered enrollment target is 2,000,000 participants, above the 20,308-participant average among 300 other Cardiovascular Diseases trials with a reported enrollment target (9748% higher). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.

View on ClinicalTrials.gov ↗

View your shortlist → Add completion date to calendar (.ics) →

The verdict

NCT03813862, a study of Cardiovascular Diseases and HIV/AIDS, is actively recruiting participants, sponsored by Epividian.

RECRUITING
Registry status
2,000,000 participants
Enrollment target
1
Study location

Study Summary

Greater advances are needed in two separate but related areas in healthcare: 1) the Clinical Decision Support Systems that complement the EHR use in support of routine patient care, population management and disease management; and 2) the use of the point-of-care observational data from the provider-patient encounter that support realworld medical research and healthcare quality measure assessment. Real-world evaluations of treatments of chronic diseases in the context of comorbid conditions and special populations (minorities, women, mentally ill, and those with addiction) are limited. The purpose of the OPERA database is to help address this unmet need in clinical research.

Primary Outcome

HIV-1 PCR laboratory value ("viral load") quantifies the amount of HIV-1 copies in plasma per mL. The baseline viral load is compared to viral load after 1 year of antiretroviral therapy.

Interventions

  • OTHER Non-interventional (observational only)

Study Locations (1)

North Carolina

  • Epividian - Durham

Trial Details

FieldValue
Enrollment Target 2,000,000 participants
Start Date 2013-12-01
Est. Completion 2035-11
Epividian

8 total trials

What NCT03813862 shows while recruiting

NCT03813862 is an observational study that tracks outcomes without assigning an intervention. Its 2,000,000 participants enrollment target places it among the larger protocols in the corpus, above the 20,308-participant average among 300 other Cardiovascular Diseases trials with a reported enrollment target (9748% higher).

The record links to 7 conditions, with Cardiovascular Diseases appearing as the primary indexed condition, and to 1 intervention - of which Non-interventional (observational only) is the first listed.

NCT03813862 reports a single indexed study location in North Carolina.

Frequently Asked Questions

What is clinical trial NCT03813862 about?

NCT03813862 is a clinical study titled "Observational Pharmaco-Epidemiology Research & Analysis". Greater advances are needed in two separate but related areas in healthcare: 1) the Clinical Decision Support Systems that complement the EHR use in support of routine patient care, population management and disease management; and 2) the use of the point-of-care observational data from the provider...

What is the current status of trial NCT03813862?

This trial is currently recruiting. The enrollment target is 2,000,000 participants. The study started on 2013-12-01. Estimated completion is 2035-11.

What conditions does trial NCT03813862 study?

This clinical trial studies the following conditions: Cardiovascular Diseases, HIV/AIDS, Inflammatory Bowel Diseases, Chronic Disease, Liver Diseases.

What interventions are being tested in trial NCT03813862?

The interventions under investigation include: Non-interventional (observational only) (OTHER).

Who is sponsoring clinical trial NCT03813862?

This trial is sponsored by Epividian, which has 8 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT03813862 being conducted?

This trial has 1 study location across North Carolina. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Similar trials for Cardiovascular Diseases

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Where NCT03813862's enrollment target sits among peer trials

2,000,000 2nd of 300 the highest of 300 other Cardiovascular Diseases trials

participants (enrollment target), bucketed by value

Each bar is a band; taller bars hold more other Cardiovascular Diseases trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.

Source ClinicalTrials.gov registry export · 2026-08-08

Nationwide trials with similar profiles

Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.

Similar enrollment target

  • NCT06057181 · 2,000,000 participants

    Helix Research Network

  • NCT07022951 · 1,200,000 participants

    The Million Anesthesia Cases Study (MACS) - a Cohort Study of Preoperative Fasting and Perioperative Outcomes

  • NCT06803498 · 3,000,000 participants

    Delivery Room Intervention and Evaluation Network

  • NCT05066763 · 1,000,000 participants

    Parkinson's Foundation Surveys

Similar registry start date

  • NCT05962346 · started 2026-12 · NA

    Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia

  • NCT07125183 · started 2026-12 · Phase 2

    Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma

  • NCT07292298 · started 2026-11 · Phase 2

    Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates

  • NCT04263285 · started 2026-10 · NA

    Treatment of Depression Post-SCI

Source: ClinicalTrials.gov NCT03813862, the US trial registry maintained by the National Library of Medicine. NCT03813862 (large enrollment · single site footprint · recruiting) retrieved and formatted by PlainTrial, see methodology.